HD-OPM Archive
Topics › PCSK9, ezetimibe & newer drugs

PCSK9 gene therapy trials had deaths, safer drugs already exist

Louis Nervegna · May 23, 2025 · ♥ 12 reactions · 9 comments · original Facebook post
PCSK9, ezetimibe & newer drugsLDL, ApoB & lipid panel
↻ This is a repost. The main version (highest ranked) is PCSK9 gene-editing therapy may not be safe yet; patient deaths occurred in a trial · Mar 18, 2025.
AI summary & key facts

Louis cautions against gene therapy to lower LDL until approved, noting deaths in a trial of Verve's therapy, cause unclear and specific to it. PCSK9 inhibitor drugs have a long safety record.

(no text — see the shared post below)

Research cited

PCSK9 gene therapies to lower LDL may not be safe.

People have died in the trials.

We have safe drugs that lower LDL very effectively, including drugs that safely inhibit PCSK9.

For most people, there is no good reason to take the risk of gene therapy to lower LDL until it is approved by the FDA and proven safe.


Please note:

These deaths were very specific to the gene therapy in this particular trial. The cause is unclear.

Nothing like this was seen in large long-running drug trials for PCSK9 inhibitors.

#genetherapyHD #pcsk9HD #verve102HD #verve101HD

← newer: Harvard: decline in US cardiovascular deaths stalled around older: CGMs are a poor guide because liver fat drives insulin resis →